De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort: CD5 positivity affects DLBCL outcome
Unc LibrariesJeremy S. Abramson +202020
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support